Alex Stojanovic
VP Business Development & Commercial Operation
Healthcare
Phosphagenics
Australia
Biography
Dr Stojanovic joined Phosphagenics in early 2014. He has spent seven years as a strategy consultant, during which time he has advised more than 30 life science companies on various aspects of business development, corporate strategy, marketing, and market access. Dr Stojanovic also served as Senior Director of Global New Compound Marketing at Grunenthal GmbH, managing the global commercial development of two pipeline pain molecules. He received a PhD in Pharmacology & Toxicology from Dartmouth College, USA and BS degrees in Chemistry and Cell & Structural Biology from the University of Illinois, USA.
Research Interest
Dr Stojanovic joined Phosphagenics in early 2014. He has spent seven years as a strategy consultant, during which time he has advised more than 30 life science companies on various aspects of business development, corporate strategy, marketing, and market access. Dr Stojanovic also served as Senior Director of Global New Compound Marketing at Grunenthal GmbH, managing the global commercial development of two pipeline pain molecules. He received a PhD in Pharmacology & Toxicology from Dartmouth College, USA and BS degrees in Chemistry and Cell & Structural Biology from the University of Illinois, USA.
